HNRPLL expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.10782519111308E-15 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.81449996641925E-09 |
Normal-vs-Stage2 |
1.178770E-04 |
Normal-vs-Stage3 |
3.24074100888083E-13 |
Normal-vs-Stage4 |
2.97799562787304E-11 |
Stage1-vs-Stage2 |
6.300200E-01 |
Stage1-vs-Stage3 |
8.702600E-03 |
Stage1-vs-Stage4 |
4.537700E-02 |
Stage2-vs-Stage3 |
6.122500E-02 |
Stage2-vs-Stage4 |
1.048610E-01 |
Stage3-vs-Stage4 |
7.713800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.63513647066793E-12 |
Normal-vs-AfricanAmerican |
3.93469999915297E-08 |
Normal-vs-Asian |
4.211000E-01 |
Caucasian-vs-AfricanAmerican |
8.646800E-01 |
Caucasian-vs-Asian |
5.551700E-02 |
AfricanAmerican-vs-Asian |
4.331800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.88737914186277E-15 |
Normal-vs-Female |
6.41560027325738E-10 |
Male-vs-Female |
8.334000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.63979999976161E-08 |
Normal-vs-Age(41-60Yrs) |
6.94600044148785E-10 |
Normal-vs-Age(61-80Yrs) |
2.87879720062278E-11 |
Normal-vs-Age(81-100Yrs) |
3.45310000005039E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.595960E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.519600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.327200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.255800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.945430E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.113800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.752100E-02 |
Normal-vs-Grade 2 |
2.09390005334598E-09 |
Normal-vs-Grade 3 |
1.23610011115716E-11 |
Normal-vs-Grade 4 |
2.77089462485947E-11 |
Grade 1-vs-Grade 2 |
3.311400E-01 |
Grade 1-vs-Grade 3 |
4.188100E-02 |
Grade 1-vs-Grade 4 |
2.760200E-02 |
Grade 2-vs-Grade 3 |
2.352200E-02 |
Grade 2-vs-Grade 4 |
9.799300E-03 |
Grade 3-vs-Grade 4 |
2.226800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.92609999458438E-08 |
Normal-vs-ccB subtype |
1.86106685617915E-12 |
ccA subtype-vs-ccB subtype |
8.210000E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.5195958087163E-11 |
Normal-vs-N1 |
2.762200E-04 |
N0-vs-N1 |
4.463600E-01 |
|
|